Table 2.
MR estimates for the association of genetically predicted liability to cholecystectomy with ischemic stroke and its subtypes
| Outcome | No. of SNPs | Method | P-value | OR (95% CI) |
|---|---|---|---|---|
| Primary outcome | ||||
| Ischemic stroke | 41 | MR-Egger | 0.104 | 0.33 (0.09–1.22) |
| Weighted median | < 0.001 | 0.14 (0.05–0.37) | ||
| IVW | 0.208 | 0.57 (0.23–1.37) | ||
| Secondary outcomes | ||||
| Small-vessel ischemic stroke | 32 | MR-Egger | 0.383 | 0.31 (0.02–4.2) |
| Weighted median | 0.042 | 0.14 (0.02–0.93) | ||
| IVW | 0.009 | 0.10 (0.02–0.57) | ||
| Large-artery atherosclerotic ischemic stroke | 39 | MR-Egger | 0.028 | 0.02 (0.001–0.58) |
| Weighted median | < 0.001 | 0.01 (0.001–0.14) | ||
| IVW | 0.023 | 0.09 (0.01–0.71) | ||
| Cardioembolic ischemic stroke | 41 | MR-Egger | 0.110 | 0.15 (0.02–1.45) |
| Weighted median | 0.054 | 0.15 (0.02–1.04) | ||
| IVW | 0.706 | 0.74 (0.16–3.47) | ||
SNP single nucleotide polymorphism, OR odds ratio, IVW inverse-variance weighted, MR-Egger Mendelian randomization-Egger